Skip to main content
Article
NMDA and Non-NMDA Antagonists Infused into the Nucleus Reticularis Pontis Caudalis Depress the Acoustic Startle Reflex
Psychology Faculty Publications
  • Mindy Miserendino, Sacred Heart University
  • Michael Davis, Yale University School of Medicine
Document Type
Article
Publication Date
10-1-1993
Abstract

Male rats chronically implanted with bilateral cannulae aimed at the nucleus reticularis pontis caudalis were tested to assess effects of γ-{d}-glutamylglycine, {d},{l}-2-amino-5-phosphonopentanoic acid (AP5), and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) on the amplitude of the acoustic startle reflex. Local infusion of each of the 3 compounds significantly reduced startle amplitude by as much as 70–80%. AP5 and CNQX attenuated startle over a dose range that indicated that the reticularis pontis caudalis may be much more sensitive to these compounds than other nuclei along the primary startle pathway. Results suggest that at the level of the nucleus reticularis pontis caudalis an excitatory amino acid neurotransmitter may mediate acoustic startle and that both N-methyl-D-aspartate (NMDA) and non-NMDA receptor subtypes may be important for the expression of the acoustic startle reflex.

Comments

Published:

Miserendino, Mindy, Davis, Michael. "NMDA and Non-NMDA Antagonists Infused into the Nucleus Reticularis Pontis Caudalis Depress the Acoustic Startle Reflex." Brain Research 623.2 (1993): 215-222.

Citation Information
Miserendino, Mindy, Davis, Michael. "NMDA and Non-NMDA Antagonists Infused into the Nucleus Reticularis Pontis Caudalis Depress the Acoustic Startle Reflex." Brain Research 623.2 (1993): 215-222.